Nagaokakyo, Japan

Atsuhiro Inaba

This inventor holds 1 USPTO granted patent. Top assignee: Takeda Chemical Industries, Inc.. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Atsuhiro Inaba. Retrieved from https://idiyas.com/inventor/atsuhiro-inaba-iu74d0si

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Atsuhiro Inaba: Innovator in Nitrogenous Fused-Ring Compounds**

Introduction

Atsuhiro Inaba is an esteemed inventor based in Nagaokakyo, Japan. He has made notable contributions to the field of pharmaceuticals, specifically through the development of nitrogenous fused-ring compounds. His innovative work is pivotal for the advancement of various therapeutic drugs.

Latest Patents

Atsuhiro holds one significant patent, which focuses on nitrogenous fused-ring compounds, the processes for their preparation, and their applications in drug development. This patent exemplifies his expertise and commitment to advancing medicinal chemistry.

Career Highlights

Inaba currently works at Takeda Chemical Industries, Inc., a leading pharmaceutical company recognized for its dedication to innovation in drug discovery and development. His role at Takeda allows him to collaborate with talented professionals and contribute to significant advancements in healthcare.

Collaborations

Throughout his career, Atsuhiro has collaborated with notable coworkers, including Masahiro Kajino and Shinji Morimoto. These partnerships enhance the collaborative environment within Takeda, fostering innovation and enabling groundbreaking research in the pharmaceutical field.

Conclusion

Atsuhiro Inaba's work exemplifies the critical role inventors play in advancing science and technology. His contributions to the development of nitrogenous fused-ring compounds not only highlight his talent but also underscore the importance of collaboration in achieving innovation within the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…